-
Novartis Pharmaceuticals Corporation et al v. Dr. Reddys Laboratories, Inc. et al DC
- 1:21-cv-01106
- D. Del.
- Judge: Maryellen Noreika
- Filed: 07/29/2021
- Closed: 12/11/2023
- Latest Docket Entry: 12/13/2023
- PACER
- Docket updated daily
2
Plaintiffs
2
Defendants
1
Accused
Product
1
Patent-in-Suit
866
Days in
Litigation
-
Novartis Pharmaceuticals Corporation et al v. Dr. Reddys Laboratories, Inc. et al DC
- 1:21-cv-01106
- D. Del.
- Judge: Maryellen Noreika
- Filed: 07/29/2021
- Closed: 12/11/2023
- Latest Docket Entry: 12/13/2023
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim | Outcome |
|---|---|
| All challenged claims |
Enforceable and Valid
Entry 101 |
-
Infringement
Dr. Reddy's Lab., Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic version of RYDAPT | US 7,973,031 B2 | All Asserted Claims |
Infringement
Entry 101
|
Dr. Reddy's Laboratories Ltd.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic version of RYDAPT | US 7,973,031 B2 | All Asserted Claims |
Infringement
Entry 101
|
